iRhythm Holdings, Inc. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
iRhythm Holdings, Inc. (IRTC) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $46.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2023-05-04
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2023-03-31 was $46.00M, a 64.29% increase year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2022-12-31 was $50.00M, a 51.52% increase year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2022-03-31 was $28.00M.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2021-12-31 was $33.00M.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2022 was $131.00M, a 48.73% decline from fiscal 2021.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2021 was $255.51M, a 77.26% increase from fiscal 2020.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2020 was $144.15M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2023-03-31 | $46.00M 10-Q · filed 2023-05-04 | $96.00M derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2022-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $131.00M 10-K · filed 2023-02-23 | ||
| 2022-09-30 | $81.00M 10-Q · filed 2022-11-04 | |||
| 2022-03-31 | $28.00M 10-Q · filed 2023-05-04 | $61.00M derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $255.51M 10-K · filed 2023-02-23 | ||
| 2021-09-30 | $222.51M 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $144.15M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |